Jun 10, 2021 / 02:30PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Good morning, everyone. I'm Matt Sykes, life sciences, tools and diagnostics analyst at Goldman Sachs. And I have the pleasure of welcoming Illumina to our conference today. I wanted to introduce Francis deSouza, the Chief Executive Officer of Illumina. Francis, thank you so much for being here with us. We really appreciate it.
Francis A. deSouza - Illumina, Inc. - CEO & Director
Thanks for having me, Matt, and thank you to the entire Goldman community for allowing me to speak to you today.
Questions and Answers:
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research AnalystGreat. And let me just start out with the brief disclaimers that, due to restriction, I cannot ask any questions about GRAIL during this session. But we have plenty of other questions that we can address.
And maybe, Francis, I'll turn it over to you first just to kind of start out and set the stage for us,
Trustpilot
